Gabriela Espinoza M.D.

Gabriela Espinoza MD is an experienced medical professional with a strong background in medical affairs and strategic planning across various therapeutic areas. Currently serving as the Medical Director for Immunoglobulins at CSL Behring and the Senior Medical Director of Strategy for Blood Disorders at Baxalta, Gabriela leads efforts in product development and medical education related to conditions such as von Willebrand Disease and Hemophilia. Previous roles include contributions to Calox International C.A. in medical education initiatives, significant advancements in global medical affairs at Eisai for epilepsy and pain management, and leadership in regional medical affairs at Pfizer, where Gabriela developed strategic plans for infectious diseases across Europe, Canada, Africa, the Middle East, and Latin America. Gabriela holds a Medical Doctor degree in Infectious Diseases from Universidad Central de Venezuela.